Yukihito Fukada
University of Yamanashi
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yukihito Fukada.
Acta Obstetricia et Gynecologica Scandinavica | 1997
Yukihito Fukada; Takehiko Yasumizu; Motoi Takizawa; Atsuhito Amemiya; Kazuhiko Hoshi
Objective. The purpose of this study was to evaluate the prognosis of fetuses with transient nuchal translucency before 15 weeks of gestation.
Journal of Obstetrics and Gynaecology Research | 2001
Rintaro Sawa; Zuisei Hayashi; Tadao Tanaka; Takekazu Onda; Kazuhiko Hoshi; Yukihito Fukada; Yasushi Takai; Yuji Taketani; Takeshi Kubo; Hiromi Hamada; Koyo Yoshida; Yasushi Nakamura; Takashi Okai; Masato Sakai; Tsuyoshi Kaneoka; Yasuo Makino; Toshihiro Aono; Kazuhisa Maeda; Ritsuo Honda; Hitoshi Okamura; Haruhiko Sago; Michihiro Kitagawa; Shigeki Minoura; Junichi Inaba; Naoki Terakawa; Naoki Nagata; Katsunori Shimomura; Michael J. Sapeta; Laurel L. Estabrooks
Objective: The purpose of this study was to assess the accuracy, informative rate, detection rate, and clinical utility of prenatal interphase fluorescence in situ hybridization (FISH) analysis of amniotic fluid samples from Japanese women.
Journal of Obstetrics and Gynaecology Research | 2000
Koyo Yoshida; Yoshinori Kuwabara; Tadao Tanaka; Takekazu Onda; Ryuichi Kudo; Hiroyuki Yamamoto; Akira Sato; Kaoru Yanagida; Takashi Okai; Masato Sakai; Yasushi Takai; Hiraku Uemura; Kazuhiko Hoshi; Yukihito Fukada; Toshihiro Aono; Kazuhisa Maeda; Sachio Ogita; Osamu Ishiko; Yuji Murata; Toru Kanzaki; Faye Myrick; Robert E. Grier
Objective: This study was conducted to assess the usefulness of dimeric inhibin A as a fourth marker for Downs syndrome screening in addition to AFP, hCG and uE3 markers for native Japanese women.
Journal of Obstetrics and Gynaecology Research | 2000
Takekazu Onda; Tadao Tanaka; Koyo Yoshida; Yasushi Nakamura; Ryuichi Kudo; Hiroyuki Yamamoto; Akira Sato; Kaoru Yanagida; Yasushi Takai; Hiraku Uemura; Kazuhiko Hoshi; Yukihito Fukada; Yoshiaki Miyake; Miyako Ohnishi; Tsuyoshi Kaneoka; Yasuo Makino; Yuji Murata; Toru Kanzaki; Hideharu Kanzaki; Takashi Osaki; Toshihiro Aono; Kazuhisa Maeda; Sachio Ogita; Seiichi Yamamasu; Takeshi Aso; Yasufumi Shimizu; Toshihiko Izutsu; Tomohiko Kudo; Takashi Okai; Masato Sakai
Objective: To report the results of prenatal triple marker screening on a population of Japanese pregnant women.
Acta Obstetricia et Gynecologica Scandinavica | 2000
Yukihito Fukada; Motoi Takizawa; Atsuhito Amemiya; Hayato Yoda; Keiko Kohno; Kazuhiko Hoshi
Fetal nuchal translucency and maternal serum screening for aneuploidy are two prenatal tests widely used throughout the world. In Japan, there have been no reports of screening for aneuploidy by fetal nuchal translucency in comparison with maternal serum markers. Here, we attempt to elucidate the prognosis of fetuses with nuchal translucency relative to those with positive maternal serum markers in Japanese women. In cases involving nuchal translucency, the study design was approved by the ethics committee of the Yamanashi University Hospital. In those of maternal serum markers, all tests were done on a voluntary basis. Informed consent was obtained from all women prior to their enrolment in the study. Nuchal translucency was defined as an abnormally high reading, more than π 2.0 standard deviations from the gestational-specific mean. Fetuses with abnormal nuchal translucency were followed by ultrasonography at 1–2 week intervals. In those with maternal serum markers, blood samples were drawn between 15.0 and 21.9 weeks of gestation. All serum samples were sent to an American laboratory, Genzyme Genetics, in Santa Fe, New Mexico. Serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol were analyzed. Multiples from the median for each marker and individual risks were calculated based
Journal of Obstetrics and Gynaecology Research | 1998
Yukihito Fukada; Yasuhiko Okuda; Takehiko Yasumizu; Kazuhiko Hoshi
If pityriasis lichenoides et varioliformis acuta (PLAVA) exists in the vagina or cervical os of the uterus, it may cause premature labor and premature rupture of the membranes.
Acta Obstetricia et Gynecologica Scandinavica | 2003
Motoi Takizawa; Takashi Kaneko; Keiko Kohno; Yukihito Fukada; Kazuhiko Hoshi
Objective. We verified whether a misdiagnosis of gestational diabetes mellitus can result in pregnant women when glucose tolerance has deteriorated after a low‐carbohydrate meal, and tried to elucidate the mechanism behind the different outcome of the test.
Neonatology | 2004
Naoki Mizobe; Kanji Sugita; Toru Tezuka; Mihoko Sakamoto; Yukihito Fukada; Kazuhiko Hoshi; Shinpei Nakazawa
To determine the expression of CD45 isoforms on T lymphocytes in neonates with fetal distress and to evaluate its diagnostic accuracy, peripheral blood samples were examined in 53 neonates who were classified into one of three groups: group I: ‘control’ group (n = 23), group II: ‘mild distress’ group (n = 15), and group III: ‘moderate distress’ group (n = 15). The expression of CD3 (mean ± SD 24.2 ± 10.1%), CD4 (23.0 ± 5.7%), and CD45RA (27.3 ± 9.6%) on total lymphocytes and the expression of CD45RA on CD4+ T lymphocytes (13.7 ± 4.7%) in group III were significantly lower than in the other two groups 0–3 days after birth. Sensitivity and specificity of the CD45RA expression on CD4+ T lymphocytes for discrimination of group III were calculated as 0.79 and 1.0, respectively, when the cutoff value was 22.7%. The low CD3, CD4, and CD45RA expression returned to normal levels 10 days and more after birth. There were no differences in the CD8 and CD45RO expression between the groups. We conclude that CD4+ T lymphocytes from neonates with fetal distress show a transient decrease in the CD45RA expression without an increase in the CD45RO expression, and, therefore, analysis of the CD45 isoform expression is useful for laboratory evaluation of fetal distress.
Journal of Obstetrics and Gynaecology Research | 2005
Yukihito Fukada; Takashi Shima; Shigeki Kawashima; Shuji Hirata; Kazuhiko Hoshi
In rare cases, patients with heterozygous hemophilia show bleeding tendency due to a low factor VIII activity of <20%. Here we describe a case of heterozygous hemophilia that developed during pregnancy. The patient was a 33‐year‐old Japanese woman whose father and brother both showed elevated nasal bleeding tendencies. However, they had received no medication for this condition. At 26 weeks’ gestation she experienced heavy nasal bleeding. The prothrombin time and platelet count were normal, but the activated partial thromboplastin time was prolonged. Premature rupture of the membrane occurred, and an emergency cesarean section was carried out at 28 weeks’ gestation. A diagnosis of heterozygous hemophilia was made after the cesarean section. Hemophilia crisis and heterozygous hemophilia require special obstetric care, with close liaison with a hematologist. Guidelines for the management of such cases should be available and observed.
Acta Obstetricia et Gynecologica Scandinavica | 1999
Yukihito Fukada; Yasumizu T; Tsurugi Y; Ohta S; Kazuhiko Hoshi